Helps manufacturers reduce cost and effort of developing devices that require regulatory approval from agencies such as the FDA, MDD, and MHRA.
OTTAWA, July 15, 2014
Building on its proven history of providing highly reliable software platforms for safety-critical environments, QNX Software Systems Limited
, a subsidiary of BlackBerry, today announced a new release of its OS for medical devices.
OS for Medical 1.1 complies with the IEC 62304 medical device standard for software life cycle processes and is designed to help manufacturers reduce the cost of developing robotic surgical instruments, patient monitoring systems, infusion pumps, blood analysis systems, and other safety-critical products that must pass stringent regulatory approval.
When it comes to medical device software, the OS sets the tone: unless it provides the architecture to enable reliable operation and a clear audit trail to substantiate claims about its dependability, the entire process of device approval can be put in jeopardy, said Grant Courville, director of product management at QNX Software Systems. By providing an OS that has been independently verified to comply with the IEC 62304 standard, we are helping manufacturers reduce the cost and effort of developing devices that require regulatory approval from agencies such as the FDA, MDD, and MHRA.
The QNX OS for Medical 1.1 is based on QNX OS technology field-proven in an array of systems for angiography, proton therapy, laser eye surgery, hemodynamic monitoring, and other critical healthcare applications. The OS supports both single-core and multi-core devices based on ARMv7 and Intel x86 processors, and it offers API compatibility with other members of the QNX OS family, enabling a high degree of software re-use.
The QNX OS for Medical 1.1 is a component of QNX Software Systems broader medical offering, which includes proven-in-use data, hazard and risk analyses, on-site audits, training courses in safe design, and professional engineering services. Customers can also choose from a rich of complement of QNX technologies, including:
- Flexible user interface technology that can blend together applications and components created with the Qt framework, HTML5, OpenGL ES, Crank Storyboard, video, and other sources.
- The QNX® Momentics® Tool Suite, an Eclipse-based development environment with profiling tools designed to help developers gain maximum insight into software behavior.
- A wide range of processors, protocols, and tools available through the extensive QNX partner ecosystem.
The QNX OS for Medical 1.1 is available now.
About QNX Software Systems
QNX Software Systems Limited, a subsidiary of BlackBerry Limited, was founded in 1980 and is a leading vendor of operating systems, development tools, and professional services for connected embedded systems. Global leaders such as Audi, Siemens, General Electric, Cisco, and Lockheed Martin depend on QNX technology for their in-car electronics, medical devices, industrial automation systems, network routers, and other mission- or life-critical applications. Visit www.qnx.com
, visit www.facebook.com/QNXSoftwareSystems, and follow @QNX_News
on Twitter. For updates on the companys automotive work, follow @QNX_Auto
and visit qnxauto.blogspot.com
A global leader in mobile communications, BlackBerry (NASDAQ:BBRY; TSX:BB) revolutionized the mobile industry when it was introduced in 1999. Today, BlackBerry aims to inspire the success of millions of customers around the world by continuously pushing the boundaries of mobile experiences. Founded in 1984 and based in Waterloo, Ontario, BlackBerry operates offices in North America, Europe, Asia Pacific, and Latin America. Visit www.blackberry.com
©2014 QNX Software Systems Limited. QNX, QNX CAR, Momentics, Neutrino, Aviage, and BlackBerry are trademarks of BlackBerry Limited and are registered and/or used in the U.S. and countries around the world, and are used under license by QNX Software Systems Limited. All other trademarks are the property of their respective owners.
QNX Software Systems Limited (QSS) is a subsidiary of BlackBerry Limited. Forward-looking statements in this news release are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. When used herein, words such as "expect", "anticipate", "estimate", "may", "will", "should", "intend", "believe", and similar expressions, are intended to identify forward-looking statements. Forward-looking statements are based on estimates and assumptions made by QSS and/or BlackBerry Limited in light of their experience and perception of historical trends, current conditions, and expected future developments, as well as other factors that QSS and/or BlackBerry believe are appropriate in the circumstances. Many factors could cause QSS and/or BlackBerrys actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements, including those described in the "Risk Factors" section of BlackBerrys Annual Information Form, which is included in its Annual Report on Form 40-F (copies of which filings may be obtained at www.sedar.com or www.sec.gov). These factors should be considered carefully, and readers should not place undue reliance on QSSs and/or BlackBerrys forward-looking statements. BlackBerry and QSS have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. QSS and/or BlackBerry are not responsible for and assume no obligations or liability and makes no representation, warranty, endorsement, or guarantee in relation to any aspect of any third-party products or services.